Vycor Medical, Inc.
VYCO
$0.1179
$0.011310.60%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -4.13% | 16.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.13% | 16.45% | |||
| Cost of Revenue | 34.60% | 57.07% | |||
| Gross Profit | -9.79% | 12.23% | |||
| SG&A Expenses | -1.63% | -3.10% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.05% | 2.32% | |||
| Operating Income | -166.32% | 154.99% | |||
| Income Before Tax | -474.63% | 88.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -474.63% | 88.80% | |||
| Earnings from Discontinued Operations | 100.00% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -476.12% | 88.80% | |||
| EBIT | -166.32% | 154.99% | |||
| EBITDA | -90.88% | 286.60% | |||
| EPS Basic | -2,900.00% | 97.01% | |||
| Normalized Basic EPS | -600.00% | 90.91% | |||
| EPS Diluted | -2,900.00% | 97.01% | |||
| Normalized Diluted EPS | -600.00% | 90.91% | |||
| Average Basic Shares Outstanding | -0.01% | 1.44% | |||
| Average Diluted Shares Outstanding | -0.01% | 1.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||